Product Details
Mint-Fluoxetine
Fluoxetine HCl10 mg
Capsule
DIN/PIN/NPN
02380560
Manufacturer
Mint Pharmaceuticals Inc.
Formulary Listing Date
2012-05-29
Unit Price
1.1773
Amount MOH Pays
NA
Coverage Status
Off-Formulary Interchangeable
ODB Formulary Therapeutic Classification
Therapeutic Note
Fluoxetine HCl: Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.
ATC Code
N06AB03
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02216582 | Teva-Fluoxetine | 1.1773 | NA |
| 02479486 | Sandoz Fluoxetine | 1.1773 | NA |
| 02018985 | Prozac | NA | NA |
| 02177579 | PMS-Fluoxetine | 1.1773 | NA |
| 02503875 | NRA-Fluoxetine | 1.1773 | NA |
| 02380560 | Mint-Fluoxetine | 1.1773 | NA |
| 02401894 | Jamp-Fluoxetine | 1.1773 | NA |
| 02374447 | Fluoxetine | 1.1773 | NA |
| 02286068 | Fluoxetine | 1.1773 | NA |
| 02242177 | Co Fluoxetine | 1.1773 | NA |
| 02448424 | Bio-Fluoxetine | 1.1773 | NA |
| 02385627 | Auro-Fluoxetine | 1.1773 | NA |
| 02216353 | Apo-Fluoxetine | 1.1773 | NA |
| 02485052 | AG-Fluoxetine | 1.1773 | NA |
| 02393441 | Ach-Fluoxetine | 1.1773 | NA |
| 02529432 | M-Fluoxetine | 1.1773 | NA |